Monovalent vaksine mot Moritella viscosa basert på cc1-isolat

Offentlig prosjektsammendrag

We are developing a new monovalent vaccine against Moritella viscosa for use in Atlantic salmon. The target of this project is to provide a vaccine that in combination with the “old” vaccines are able to protect against all currently circulating pathogenic M.viscosa strains. The main focus of the project will be to select candidate strains that have cross-protective properties and also are suitable for industrial production with standard up-stream and down-stream processes. This development will increase our understanding respecting Moritella genetics and virulence, as well as delivering new knowledge to Vaxxinova respecting novel upstream processes for vaccine manufacturing. Overall, we expect to offer a new, improved solution against Moritella viscosa for Nording Salmon farming industry.